Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats

被引:22
|
作者
Zhang, Zhengyu [1 ]
Tachikawa, Masanori [1 ]
Uchida, Yasuo [1 ]
Terasaki, Tetsuya [1 ]
机构
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi 9808578, Japan
关键词
blood-cerebrospinal fluid barrier; blood-arachnoid barrier; pharmacokinetics; organic anion transporters; oat1; oat3; leptomeninges; BLOOD-BRAIN-BARRIER; TARGETED ABSOLUTE PROTEOMICS; CANCER RESISTANCE PROTEIN; CHOROID-PLEXUS; P-GLYCOPROTEIN; FUNCTIONAL-CHARACTERIZATION; QUANTITATIVE ATLAS; JUNCTION PROTEINS; EXPRESSION LEVELS; SURROGATE;
D O I
10.1021/acs.molpharmaceut.7b00852
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Although arachnoid mater epithelial cells form the blood-arachnoid barrier (BAB), acting as a blood-CSF interface, it has been generally considered that the BAB is impermeable to water-soluble substances and plays a largely passive role. Here, we aimed to clarify the function of transporters at the BAB in regulating CSF clearance of water-soluble organic anion drugs based on quantitative targeted absolute proteomics (QTAP) and in vivo analyses. Protein expression levels of 61 molecules, including 19 ATP-binding-cassette (ABC) transporters and 32 solute-carrier (SLC) transporters, were measured in plasma membrane fraction of rat leptomeninges using QTAP. Thirty-three proteins were detected; others were under the quantification limits. Expression levels of multidrug resistance protein 1 (Mdr1a/P-gp/Abcb1a) and breast cancer resistance protein (Bcrp/Abcg2) were 16.6 and 3.27 fmol/mu g protein (51.9- and 9.82-fold greater than in choroid plexus, respectively). Among those organic anion transporters detected only at leptomeninges, not choroid plexus, organic anion transporter 1 (oat1/Slc22a6) showed the greatest expression (2.73 fmol/mu g protein). On the other hand, the protein expression level of oat3 at leptomeninges was 6.65 fmol/mu g protein, and the difference from choroid plexus was within two-fold. To investigate oat1's role, we injected para-aminohippuric acid (PAH) with or without oat1 inhibitors into cisterna magna (to minimize the contribution of choroid plexus function) of rats. A bulk flow marker, FITC-inulin, was not taken up from CSF up to 15 min, whereas uptake clearance of PAH was 26.5 mu L/min. PAH uptake was completely blocked by 3 mM cephalothin (inhibits both oat1 and oat3), while 17% of PAH uptake was inhibited by 0.2 mM cephalothin (selectively inhibits oat3). These results indicate that oat1 and oat3 at the BAB provide a distinct clearance pathway of organic anion drugs from CSF independently of choroid plexus.
引用
收藏
页码:911 / 922
页数:12
相关论文
共 50 条
  • [21] Functional analysis of genetic variants of the human organic anion transporter, OAT (SLC22A6)
    Fujita, T
    Leabman, MK
    Brown, C
    Fujita, K
    Giacomini, KM
    Majima, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 281P - 281P
  • [22] Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice:: A gender specific impact of reduced folates
    VanWert, Adam L.
    Sweet, Douglas H.
    PHARMACEUTICAL RESEARCH, 2008, 25 (02) : 453 - 462
  • [23] Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G
    VanWert, Adam L.
    Bailey, Rachel M.
    Sweet, Douglas H.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 293 (04) : F1332 - F1341
  • [24] Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice
    Sykes, D
    Sweet, DH
    Lowes, S
    Nigam, SK
    Pritchard, JB
    Miller, DS
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 286 (05) : F972 - F978
  • [25] Impaired Clearance of Methotrexate in Organic Anion Transporter 3 (Slc22a8) Knockout Mice: A Gender Specific Impact of Reduced Folates
    Adam L. VanWert
    Douglas H. Sweet
    Pharmaceutical Research, 2008, 25 : 453 - 462
  • [26] Identification and functional characterization of variants of the human organic anion transporter, OAT3 (SLC22A8).
    Mangravite, L
    Erdman, A
    Giacomini, KM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P93 - P93
  • [27] Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient
    Sweet, DH
    Chan, LMS
    Walden, R
    Yang, XP
    Miller, DS
    Pritchard, JB
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 284 (04) : F763 - F769
  • [28] The human organic anion transporter 3 (OAT3; SLC22A8):: genetic variation and functional genomics
    Erdman, AR
    Mangravite, LM
    Urban, TJ
    Lagpacan, LL
    Castro, RA
    de la Cruz, M
    Chan, W
    Huang, CC
    Johns, SJ
    Kawamoto, M
    Stryke, D
    Taylor, TR
    Carlson, EJ
    Ferrin, TE
    Brett, CM
    Burchard, EG
    Giacomini, KM
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (04) : F905 - F912
  • [29] Organic anion transporter 3 [Slc22a8] is a dicarboxylate exchanger indirectly coupled to the Na+ gradient
    Sweet, DH
    Chan, LMS
    Walden, R
    Yang, XP
    Miller, DS
    Pritchard, JB
    FASEB JOURNAL, 2003, 17 (04): : A477 - A478
  • [30] Human Organic Cation Transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as Disposition Pathways for Fluoroquinolone Antimicrobials
    Mulgaonkar, Aditi
    Venitz, Juergen
    Gruendemann, Dirk
    Sweet, Douglas H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) : 2705 - 2711